Max Robotics — Global Service Robot Directory + US Certification

About

Alessandro Crepaldi is a thoracic surgeon and researcher advancing the frontiers of minimally invasive lung surgery and postoperative care. His primary research focuses on enhancing recovery after robotic lobectomy, where he has pioneered protocols for ultra-early hospital discharge. In his landmark pilot study, Crepaldi demonstrated that patients could be safely discharged on postoperative day two—a dramatic reduction from the standard four-day stay—by leveraging telehealth home monitoring devices. This work, which has garnered over 11 citations, challenges conventional recovery timelines and offers a blueprint for reducing healthcare costs while maintaining patient safety. Crepaldi has also made critical contributions to understanding postoperative pneumonia after lung cancer surgery. His retrospective cohort study identified key risk factors and pathogens responsible for this complication, which affects up to 12% of patients and can lead to respiratory failure and increased mortality. By pinpointing modifiable risk factors, his research provides actionable insights for prevention. Crepaldi’s work sits at the intersection of surgical innovation and digital health, positioning him as a leader in the evolution of thoracic surgery toward safer, more efficient, and patient-centered care.